Acetylcysteine — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

2 Recruiting

4 Completed trials

11 Sponsors

9 Countries

Phase III

Phase IV

Phase III: 4 Phase II: 1 Phase I/II: 1 Phase III/IV: 1 Phase IV: 4

Indications tested

Chondrosarcoma 1 Retinitis pigmentosa 1

Sponsors using this IMP

Asociacion Instituto Biogipuzkoa 1 Asociacion Instituto De Investigacion Sanitaria Bioaraba 1 Centre Hospitalier Universitaire De Nantes 1 Copenhagen University Hospital 1 E Pharma Trento S.p.A. 1 Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience 1 Inhibrx Biosciences Inc. 1 Johns Hopkins University 1 Leiden University Medical Center 1 Region Hovedstaden 1 UZ Brussel 1

All trials

11 total

Randomized, multiCentre, dOuble-blind, double-duMmy, parallel-group clinical study on efficacy and safety of iBuprofen/N-acetylcysteine fixe… Not authorised

2023-505809-17-00 Phase III 1 country E Pharma Trento S.p.A.
Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections (IMPACT) Not authorised

2025-522215-42-00 Phase IV 1 country Copenhagen University Hospital
Utility of the use of N-acetylcisteine associated with conventional treatment in patients with severe acute alcoholic hepatitis (Maddrey>=32… Pending

2023-510163-35-00 Phase III 1 country Asociacion Instituto De Investigacion Sanitaria Bioaraba
Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial Pending

2025-520573-39-00 Phase IV 1 country Groupe Hospitalier Universitaire Paris Psychiatrie Et Neuroscience
IMPACT-NAC: A clinical trial of N-acetylcysteine for adults with severe infection and liver dysfunction Pending

2026-525895-25-00 Phase IV 1 country Region Hovedstaden
A PHASE II, SINGLE-CENTER, RANDOMIZED DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF THE COMBINED THERAPY OF EH-301 AND N-… Recruiting

2024-519857-13-00 Phase I/II 1 country Asociacion Instituto Biogipuzkoa
PROlonged Corticosteroid treatment or N-ACetylcysteine for severe alcoholic hepatitis (PROCORNAC) Recruiting

2025-522109-39-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Or… Ended

2022-501438-46-00 Phase III 3 countries Johns Hopkins University
A Phase 2 study of INBRX-109 in adults with a type of unresectable or metastasized cancer of the bones and joints (Conventional Chondrosarco… Ended

2024-517528-20-00 Phase II 6 countries Inhibrx Biosciences Inc.
N-acetylcysteine for the treatment of cannabis dependence: working mechanisms Ended

2024-519855-27-00 Phase IV 1 country UZ Brussel
Effect of a pain killer on breathing and another drug that stimulates breathing Ended

2023-503912-34-00 Phase III/IV 1 country Leiden University Medical Center

Showing 1–11 of 11 trials

← All drugs A–Z